Causation, remoteness of damage, and defences

JurisdictionUnited Kingdom
Pages673-769
AuthorDuncan Fairgrieve,Richard Goldberg
673
17
CAUSATION, REMOTENESS OF DAMAGE,
ANDDEFENCES
A. Causation and Remoteness of Damage 17.01
(1) Introduction 17.01
(2) Causation in fact 17.04
(3) Remoteness of damage 17.73
(4) Strict liability and causation under the
Consumer Protection Act 1987 17.104
(5) Conclusion 17.121
B. Contributory Negligence and
Abnormal Use 17.123
(1) Introduction 17.123
(2) Claims in negligence 17.126
(3) Contributory fault and strict liability 17.130
C. Voluntary Assumption of Risk:
Knowledge and Exemption
Clauses 17.135
(1) Voluntary assumption of risk 17.135
(2) Knowledge of the claimant 17.138
(3) Exemption and limitation clauses 17.141
D. Limitation Periods 17.143
(1) Introduction 17.143
(2) Claims under the Consumer Protection
Act 1987 17.144
(3) Claims in negligence 17.164
(4) Law Commission recommendations 17.172
A. Causation and Remoteness of Damage
(1) Introduction
One of the most important and complex elements in many product liability actions is the
establishment of a causative link between the allegedly defective product and the relevant
damage.1 Indeed, the signicance of causation cannot be overstated since, whether the claim is
in negligence or under the Consumer Protection Act 1987, proof of causation will often lead
to either a settlement or a successful claim.2
Conversely, a failure to establish a causal link between a product and, for example, the al-
leged medical conditions of claimants, may lead to such claims being struck out as an abuse
of the process of the court on the basis that each claim has no real prospect of success.3
1 See, generally, Markesinis and Deakin’s Tort Law, 218– 56; Clerk & Lindsell, Torts 2–01–2–177, 55–
112; Wineld & Jolowicz, Tor t, paras 7.1– 7.46; R Goldberg, ‘Causation’ in G Howells (ed), e Law of
Product Liability, 285– 319; R Goldberg, Perspectives on Causation (Hart Publishing, 2011); S Steel, Proof of
Causation in Tort Law (CUP, 2015); S Green, Causation in Negligence (Hart Publishing, 2015).
2 M Mildred, ‘Representing the plainti’ in G Howells (ed), Product Liability, Insurance and the
Pharmaceutical Industry: An Anglo- American Comparison (Manchester University Press, 1991), 27.
Nevertheless, this is not always the case. Cf M Mildred, ‘Group Litigation’ in Miller, Product Liability and
Safety Encyclopaedia, paras 158– 211.
3 us in Re Organophosphate Group Litigation; Herbert George Snell & Others v Robert Young & Co Ltd
& Others [2002] EWCA Civ 1644, [2002] All ER (D)310, a number of claims were brought under the
Consumer Protection Act 1987 against the manufacturers of sheep dips. e claimants alleged that exposure
to the organophosphates in the dips caused a series of medical conditions. At a preliminary stage in the pro-
ceedings it was decided to carry out a medical pilot study to seek to establish if there was a causal link between
17.01
17.02
Product Liability. Third Edition. Duncan Fairgrieve and Richard Goldberg, Oxford University Press (2020).
© Duncan Fairgrieve and Richard Goldberg 2020 DOI: 10.1093/oso/9780199679232.003.0021
Causation, Remoteness of Damage, and Defences
674
In general, the relevant principles are the same whatever the basis of liability which is
pleaded, although in negligence the focal point of the inquiry is on whether the alleged
breach of duty caused the damage, whereas in claims under the 1987 Act the emphasis is
on proving the link between the alleged defect and the damage in question.4
In the discussion which follows many of the general principles have been established in
cases decided under the general law of negligence. Frequently, the cases have not involved
defective products, but the principles are of general application. As with the law of caus-
ation in negligence generally, it will be necessary to examine the development of the law as
it relates to defective products in two stages, namely in terms of causation in fact, which
concerns itself with demonstrating a factual link between the defendant’s negligence and
the damage, and then, if causation in fact is satised, with remoteness of damage, where
the court assesses whether the consequences of the tort that occurred on the relevant occa-
sion should be judged to be within the scope of the defendant’s liability.5 In both factual
causation and remoteness of damage, ‘[t] he policy of the law plays a signicant role’.6
(2) Causation in fact
(a) Introduction
Under the law of negligence, the claimant must prove a causal link between the defendant’s
negligence and the injury in question. In the context of product liability litigation, it must also
be proved on a balance of probabilities that the defendant’s product caused or materially con-
tributed to the damage in issue. e latter requirement exists irrespective of whether the claim
is in contract or in tort and whether liability is strict or dependent on proof of negligence.
(b) Proving a causal link betweenproduct anddamage
(i) Scientific evidence, epidemiology, and doubling of risk Proof of a causal link be-
tween the product and the damage is often inherently dicult, requiring time- consuming
and detailed examination by the court of complex scientic evidence, which is often con-
icting. For example, in Ashington Piggeries v Christopher Hill Ltd,7 the defendants suc-
ceeded in proving, after a fty- day trial in the High Court, that the death of their mink
was caused by the presence of the contaminating chemical dimethylnitrosamine (DMNA)
in the herring meal of the plaintis’ mink feed.8
exposure and the medical conditions suered by the various claimants. e pilot study was ‘at best inconclu-
sive’ and thus oered little support for the establishment of causation. e Court of Appeal upheld the trial
judge’s decision to strike out the claims as an abuse of process:ibid, paras 27, 39– 42 per Simon Brown L J.
4 For discussion of issues which arise specically under the 1987 Act and of possible reforms, see paras
17.104– 17.120.
5 J Stapleton, ‘Cause- in- Fact and the Scope of Liability for Consequences’ (2003) 119 LQR 388, 391. Prof
Stapleton has reclassied the term remoteness of damage as ‘scope of liability’:ibid, 391, 411.
6 Clerk & Lindsell, Torts, para 2- 06; see also Markesinis and Deakin’s Tor t Law, 185– 6.
7 [1972] AC 441, [1971] 1 All ER 847.
8 e trial judge’s nding as to the cause of mortality was upheld by the Court of Appeal and was not chal-
lenged in the House of Lords. See also Wright v Dunlop Rubber Co Ltd [1972] 13 KIR 255 (cancer from indus-
trial chemicals). Cf the American litigation concerning Bendectin (Debendox), the anti- nausea drug used in
pregnancy. In contrast to thalidomide, where many lines of evidence showed that the drug caused phocomelia
malformations (see H Sjöström and R Nilsson, alidomide and the Power of Drug Companies (Penguin, 1972),
156– 9), no causal link has been scientically established between Bendectin and birth defects. e Bendectin
Litigation demonstrated a repeated failure of plaintis’ lawyers to prove causation:Goldberg, Causation and
Risk in the Law of Torts:Scientic Evidence and Medicinal Product Liability, 102– 31; J Sanders, ‘e Bendectin
17.03
17.04
17.05
Causation and Remoteness of Damage
675
In recent years, the cases have become even more complex, demanding much from lawyers
on both sides and the judges themselves.9 us the satisfactory establishment of causation
through scientic evidence is often essential for success. Increasingly, where non- numerical
solutions would prove elusive the courts are reliant on experts to provide details of statis-
tical evidence in ascertaining cause.
ere is an ‘apparent tension’10 between the levels of evidential proof of causation for
purposes of science and for the law. For the law of negligence, it is enough to show that
the balance of probabilities— meaning more than 50 per cent,11 or on a preponderance of
the evidence— indicates a causal connection. It has been sometimes erroneously assumed
by lawyers that scientists regard an association as causal if it is 95 per cent certain,12 but
this is a misinterpretation of the so- called p value, which is merely the level of statistical
signicance required to exclude the possibility that something transpiring in a cohort of
Litigation:A Case Study in the Life Cycle of Mass Torts’ 43 Hastings LJ 301 (1992); M Green, Bendectin
and Birth Defects:e Challenges of Mass Toxic Substances Litigation (University of Pennsylvania Press, 1996); J
Sanders, Bendectin on Trial:A Study of Mass Tort Litigation (University of Michigan Press, 1998).
9 See eg Loveday v Renton [1990] 1 Med LR 117, where Stuart- Smith LJ, after examining complex sci-
entic evidence and arguments, held that the plainti had failed to prove on a balance of probabilities that
pertussis (whooping cough) vaccine could cause permanent brain damage in young children:[1990] 1 Med
LR 117, 185; and Reay v British Nuclear Fuels; Hope v BNFL [1994] 5 Med LR 1, 53, where French J held that
the plaintis had failed to establish that paternal preconception irradiation was a material contributory cause
of childhood leukaemia of Dorothy Reay or non- Hodgkin’s Lymphoma of Vivien Hope; also Davis & Doherty
v Balfour Kilpatrick [2002] EWCA Civ 736 where claimants failed to establish that their alleged radiation
sickness was caused by radio frequency emissions. e Court of Appeal conrmed the important point (citing
e Popi M [1985] 1 WLR 948, HL) that the trial court judge was not obliged to make a positive nding as
to what was the cause of such symptoms. See further, Milton Keynes Borough Council v Nulty [2013] EWCA
Civ 15, [2013] 1 WLR 1183, [34] per Toulson LJ. However, such cases are rare. Cf where there are two com-
peting explanations ‘which though they may be uncommon, are not improbable’, then once one cause has
been eliminated, the judge is entitled to conclude that the other was the probable cause of the damage:Ide
v ATP Sales Ltd [2008] EWCA Civ 424, [2009] RTR 8, [4] , [19]– [20]. See also Frankfurt Court of Appeal,
10 April 2003 (10 u 30/ ou), NJW- RR 2003, pp 1177– 9, noted in U Froelich, ‘Dental Fillings Manufacturer
not Liable for Health Problems’, Lovells’ European Product Liability Review, December 2003, Issue 13, 42– 3
(manufacturer of amalgam tooth llings not liable for chronic mercury poisoning resulting in disseminated
sclerosis and infertility since the claimant had failed to prove a causal link between the alleged injuries and the
dental lling material). See also para 17.63.
10 R Goldberg, ‘Epidemiological Uncertainty, Causation, and Drug Product Liability’ (2014) McGill LJ
777, 784– 5.
11 e expression of the balance of probabilities as more than 50 per cent may ‘carry with it a danger of
pseudo- mathematics’. While process may include evaluation of scientic evidence it ‘is not scientic. . .and
to express the probability of some event having happened in percentage terms is illusory’:Milton Keynes
Borough Council v Nulty [2013] EWCA Civ 15, [2013] 1 WLR 1183, [35] per Toulson LJ.
12 See MD Green, DM Freedman, and L Gordis, ‘Reference Guide on Epidemiology’ in Reference
Manual on Scientic Evidence (3rd edn, National Academies Press, 2011), 576– 7; equating statistical sig-
nicance with the legal burden of proof has been described as being ‘like trying to nd the shortest path
from Oxford to Cambridge by scrutinizing a map of London’:DH Kaye, ‘Apples and Oranges:Condence
Coecients and the Burden of Persuasion’ 73 Cornell L Rev54, 66 (1987). ere is often judicial ref-
erence to a statement that the level of 0.05 for statistical signicance is a much higher burden of proof
than the civil burden of a preponderance of the evidence or balance of probabilities (viz greater than 50
per cent:MD Green, DM Freedman, and L Gordis, ‘Reference Guide on Epidemiology’ in Reference
Manual on Scientic Evidence 577, citing In re Ephedra Prods Liab Litig 393 F Supp 2d 181, 193 (SDNY,
2005); Marmo v IBP, Inc 360 F Supp 2d 1019, 1021 (D Neb, 2005); P Feldschreiber, L Mulcahy, and S
Day, ‘Biostatistics and Causation in Medicinal Product Liability Suits’ in R Goldberg (ed), Perspectives on
Causation (Hart Publishing, 2011), 190. Recent case law has referred to Wyeth’s citation of the Reference
Manual on Scientic Evidence to point to the erroneous nature of this approach:Giles v Wyeth, Inc 500 F
Supp 2d 1048, 1056– 7 (SD Ill, 2007).
17.06
17.07

Get this document and AI-powered insights with a free trial of vLex and Vincent AI

Get Started for Free

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex